Lipoxin analogs as novel inhibitors of angiogenesis
AssigneeThe Brigham and Women's Hospital, Inc.
InventorsCharles N. Serhan, Iolanda M. Fierro
Life of this patent
Estimating the term…
Abstract
The present invention is directed to methods for the prevention or inhibition of angiogenesis. The method is accomplished by the administration of an effective amount of 15-epi-16-(para-fluoro)-phenoxy-lipoxin A4, LXA4, 15-epi-LXA4 or 15-R/S-methyl, LXA4 and pharmaceutically acceptable salts, esters, amides, carboxylic acids, or prodrugs thereof, to a subject in need thereof. As a consequence of the action of the therapeutic agent, angiogenesis is prevented or inhibited in the subject.
Claims1
A method to increase vascular or endothelial cellular proliferation in a subject in need of wound healing comprising the step of administering to the subject in need of wound healing, an effective amount of an LXB4 compound or pharmaceutically acceptable salts, esters, and amides thereof wherein the LXB4 compound is selected from 14-epi-LXB4, 15-epi-LXB4 and 15-epi-LXB4-acetylenic such that vascular or endothelial cellular proliferation in the subject in need of wound healing is increased.
Dependencies are inferred from the claim text.